Arabic Arabic English English French French German German
dark

Mainz Biomed enters agreement Socpra Sciences on colorectal cancer test

Mainz Biomed has entered into a Technology Rights Agreement with Socpra Sciences Santé Et Humaines S.E.C. (“TTS”) to access a portfolio of novel mRNA biomarkers for potential future integration into ColoAlert, a colorectal cancer test. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Willis Towers Watson releases new branding

Next Post

Breaking down the barriers of nursing behind closed doors

Related Posts
Total
0
Share